304 related articles for article (PubMed ID: 15755289)
1. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
Pouplard C; May MA; Regina S; Marchand M; Fusciardi J; Gruel Y
Br J Haematol; 2005 Mar; 128(6):837-41. PubMed ID: 15755289
[TBL] [Abstract][Full Text] [Related]
2. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
3. Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia.
Zucker MJ; Sabnani I; Baran DA; Balasubramanian S; Camacho M
J Heart Lung Transplant; 2010 Jan; 29(1):53-60. PubMed ID: 19819167
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
[TBL] [Abstract][Full Text] [Related]
5. Hypothermic cardiopulmonary bypass as a determinant of late thrombocytopenia following cardiac operations in pediatric patients.
Ranucci M; Carlucci C; Isgrò G; Brozzi S; Boncilli A; Costa E; Frigiola A
Acta Anaesthesiol Scand; 2009 Sep; 53(8):1060-7. PubMed ID: 19496765
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
[TBL] [Abstract][Full Text] [Related]
7. Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature.
Jaben EA; Torloni AS; Pruthi RK; Winters JL
J Clin Apher; 2011; 26(4):219-24. PubMed ID: 21506142
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
9. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
[TBL] [Abstract][Full Text] [Related]
10. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
[TBL] [Abstract][Full Text] [Related]
11. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test.
Dellaria SM; Greilich PE; Sarode R
Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
14. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.
Berry C; Tcherniantchouk O; Ley EJ; Salim A; Mirocha J; Martin-Stone S; Stolpner D; Margulies DR
J Am Coll Surg; 2011 Jul; 213(1):10-7; discussion 17-8. PubMed ID: 21531584
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
16. Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery.
Selleng S; Malowsky B; Itterman T; Bagemühl J; Wessel A; Wollert HG; Warkentin TE; Greinacher A
Am Heart J; 2010 Aug; 160(2):362-9. PubMed ID: 20691844
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.
Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y
Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918
[TBL] [Abstract][Full Text] [Related]
18. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
19. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens.
Selleng K; Schütt A; Selleng S; Warkentin TE; Greinacher A
Transfusion; 2010 Jan; 50(1):32-9. PubMed ID: 19709391
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass.
Hanson SJ; Punzalan RC; Ghanayem N; Havens P
Pediatr Crit Care Med; 2007 Jul; 8(4):358-61. PubMed ID: 17545932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
